![Jack Talley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Talley
Amministratore Delegato presso
Mitotherapeutix LLC
Profilo
Jack Talley is currently Chief Executive Officer & Director at Mitotherapeutix LLC since 2018 and Director at IGF Oncology LLC.
Former roles include President, Chief Executive Officer & Director at Cactus Ventures, Inc. from 2012 to 2013; President, Chief Executive Officer & Director at EpiCept Corp.
from 2011 to 2012; Chief Executive Officer at Consensus Pharmaceuticals, Inc.; Chief Executive Officer at Actinium Pharmaceuticals, Inc. from 2012 to 2013; President at Actinium Pharmaceuticals, Inc. in 2013; President & Chief Operating Officer at Penwest Pharmaceuticals Co. Education includes undergraduate studies at the University of Connecticut.
Posizioni attive di Jack Talley
| Società | Posizione | Inizio |
|---|---|---|
IGF Oncology LLC
 IGF Oncology LLC BiotechnologyHealth Technology Develops novel cancer drugs | Direttore/Membro del Consiglio | - |
Mitotherapeutix LLC
 Mitotherapeutix LLC BiotechnologyHealth Technology Develops products for treatment of diseases by modifying or influencing metabolic pathways in the cell | Amministratore Delegato | 01/07/2019 |
Precedenti posizioni note di Jack Talley
| Società | Posizione | Fine |
|---|---|---|
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Presidente | 18/04/2013 |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Presidente | 01/03/2013 |
| ACTINIUM PHARMACEUTICALS, INC. | Amministratore Delegato | 28/02/2013 |
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Presidente | 20/08/2012 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Presidente | - |
Formazione di Jack Talley
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
38
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Consensus Pharmaceuticals, Inc. | |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Mitotherapeutix LLC
Mitotherapeutix LLC BiotechnologyHealth Technology Develops products for treatment of diseases by modifying or influencing metabolic pathways in the cell | Health Technology |
IGF Oncology LLC
IGF Oncology LLC BiotechnologyHealth Technology Develops novel cancer drugs | Health Technology |
